Pharma business info

Notwithstanding the debate surrounding the fall in rates of anti-cancer medications, Indian pharma major Cipla is eyeing to slash rates of at least six more products-much in lines of cutting of anti-AIDS medications a decade ago-to make them reasonable for patients.

Shares of Arena Pharmaceuticals Inc. nearly doubled in cost in premarket trading on May 11, the day after FDA consultants recommended nod for its potential weight-loss medication, lorcaserin.

Taro Pharmacetical Industries Ltd. declared that the Special group of its Board of Directors set up to assess the offer from Sun Pharmaceutical Industries Ltd.

Swiss pharma giant Novartis stated that it is purchasing dermatology generics firm Fougera for around $1.525 billion, a move that would propel the group to market head spot on generic dermatology medications.

Watson Pharmaceuticals first-quarter income surged 22% as the drug manufacturer announced sharply higher income with a boost from novel generic medications and as its branded pharmaceuticals and distribution biz also registered double-digit growth.

Endo Pharmaceuticals posted a first-quarter loss after assimilating a $110-million pre-tax charge linked to a settlement and license agreement with Impax Laboratories Inc.

The Chennai-based global pharma major Orchid Chemicals& Pharmaceuticals Ltd. declared obtaining the nod from the USFDA for its ANDA for Olanzapine pills in the potencies comprising 2.5mg, 5mg, 7.5mg, 10mg, 15mg and 20 mg.

Natco Pharma Limited has been chosen as the National Award victor of the 'Golden Peacock Award for Corporate Social Responsibility' for the year 2012.

US drug manufacturer Jazz Pharmaceuticals stated that it has inked a definitive deal to get hold of privately-held, UK-headquartered EUSA Pharma for $650 million in cash and a potential $50 million landmark.

Watson Pharmaceuticals has purchased Actavis for approximately $5.6 billion, paying $1 billion less for the Swiss generic drug manufacturer than initial M&A hearsays had hinted.

Pfizer Inc., the globe’s largest drug manufacturer, and Mylan Inc. stated that they settled patent-infringement lawsuit with Teva Pharmaceutical Industries Ltd. over a device utilized to insert epinephrine during potentially fatal allergies.

Drugmaker Jazz Pharmaceuticals PLC stated that it will get hold of cancer drug manufacturer EUSA Pharma Inc. in a transaction worth around $700 million.

Shares of diabetes drug manufacturer Amylin Pharmaceuticals Inc. soared on April 23 accompanying a report the firm is reaching out to prospective buyers on a possible sale.

Sun Pharmaceutical Industries Ltd. has announced that USFDA has given nod for its Abbreviated New Drug Application for generic edition of Zyprexa, Olanzapine tabs USP, 2.5mg, 5mg, 7.5mg,10mg, 15mg and 20mg

Pfizer Pfizer is determined on throwing away noncore biz groups. AstraZeneca is intent on appending any small firm, which might bring returns.

Novartis AG's (NVS) head of pharmaceuticals David Epstein stated that Gilenya will be a smash hit in spite of the improbability surrounding the multiple sclerosis tablet's safety.

SXC Health Solutions Corp stated that will purchase rival pharmacy benefit manager Catalyst Health Solutions Inc for $4.4 billion as it tries to keep pace in the speedily consolidating market for managing Americans' prescriptions.

Research-based pharmaceutical and healthcare firm Glaxosmithkline stated that it has reached deal to sell the previously recognized non-core OTC brands in its global markets to Aspen Pharmacare Holdings Ltd. for GBP164 million in cash.

After its second acquirement of molecular imaging development group of Germany's Bayer Pharma, Piramal Healthcare is looking at additional buyouts in pharmaceutical, home finance as well as home security systems businesses.

Vanda Pharmaceuticals Inc. stated that it has got hold of an exclusive international license from Eli Lilly and Co. in order to build up and market a small molecule neurokinin 1 receptor, or NK-1R, antagonist for all human indications.

Sun Pharmaceutical Industries has declared that USFDA has granted its arm an approval for its ANDA for generic edition of Seroquel, quetiapine fumarate tabs, in various potencies.

Sherilyn McCoy, a vice chairman of the Johnson & Johnson executive board, resigned to take the top post at cosmetics company Avon.

Avon Products, the cosmetics firm that has been under pressure amid a regulatory probe and slumping sales, has appointed a new leader.

Recently, Allos Therapeutics, and Spectrum Pharmaceuticals entered into a deal through which the latter decided to get hold of the former for $1.82 a share in cash, besides one contingent value right (CVR).

Optimer Pharmaceuticals Inc. (OPTR) has shaken up its control, mentioning lapses in corporate governance practices and the drug manufacturer's connection with a Taiwanese associate.

Tokyo-based Astellas Pharma has announced that its proposed medicine for addressing overactive bladder - Mirabegron, bagged the support of an FDA advisory board.

China’s pharmaceutical industry has registered a 21.4% y-o-y increase in output value for the initial two months to 234.27 billion yuan, with the growth rate down 7.1 percentage points as against the last year.

Scrip of Spectrum Pharmaceuticals declined on Thursday after the drug maker stated that a potential cancer cure missed its main objective in late-stage test.

When President Barack Obama entered into the Patient Protection and Affordable Care Act (PPACA), commonly known as "Obamacare," during March 2010, it received large amounts of extolment and unfavorable judgment. The majority of individuals seem to feel sturdily in one direction or the other.

Scrip of drug manufacturer Aurobindo Pharma saw huge selling pressure after the firm’s MD was named in a chargesheet lodged by the Central Bureau of Investigation (CBI).

Gerresheimer AG, a German supplier of pharma and healthcare products has got hold of 70% equity stake in the Indian bottles manufacturer Neutral Glass & Allied Industries Pvt Ltd for an unrevealed sum.